Defense
Environment Alert
an
exclusive
biweekly report on defense policies for cleanup, compliance and
pollution
prevention
Vol. 15, No. 3
February 6, 2007
ARMY
TO FOLLOW GAO ADVICE ON NEW COST ANALYSIS FOR VX WASTE
Findings and recommendations by the Government Accountability Office
(GAO) about a dropped Army plan to treat nerve agent waste at a
DuPont-owned facility are expected to play a role in the Army's
yet-to-be-named waste treatment plan to replace the DuPont plan.
The Army must treat millions of gallons of wastewater resulting from
the neutralization of VX nerve agent at its Newport, IN, facilty.
In a Jan. 26 report, GAO, which was tasked by congressional defense
authorizers to conduct the study, foundthe Army's underlying cost
estimates for the DuPont plan "were not reliable." GAO, in the report,
questions the Army's conclusions that its DuPont treatment plan had
significant cost advantages to three other alternatives. The report
comes shortly after DuPont pulled out of the Army waste treatment
contract.
GAO revised the report prior to its release to reflect DuPont's Jan. 5
decision to drop out. of the plan. The congressional investigative arm
calls on the Army to conduct a new cost-benefit analysis that relies on
best practices established by the White House Office of Management
& Budget and professional cost analysts.
Use of these practices should ensure that the Army's data and
conclusions in evaluating technology options are "comprehensive,
traceable, accurate, and credible," GAO says. The report is available on InsideEPA. com.
Seepage 2 for details.
The Army plans to perform the new cost-benefit analysis when it
restarts its evaluation of potential technologies to treat the nerve
agent waste, according to a spokesman for the Army's
Chemical Materials Agency (CMA), which oversees much of the chemical
weapons destruction program. The Army is
currently neutralizing the VX nerve agent stockpiled at its Newport
site and storing it on-site until it
decides on a secondary treatment option for the waste and final
disposal. When all of the agent is neutralized, the
Army will have about 4 million gallons of wastewater in need of
treatment.
DuPont's Chamber Works facility in Deepwater, NJ, was the second
off-site facility the Army had chosen to treat the VX waste, following
a failed attempt to send it to a facility
in Dayton, OH. In both cases, public opposition was strong. Activists,
New Jersey politicians and others argued it
should be addressed on-site, rather than shipped off-site for further
treatment. DuPont pulled out shortly after
environmentalists filed a lawsuit challenging the Army's latest
transport and treatment plan, saying it was facing an
approval process that would "be lengthy and arduous."
The Army now plans to consider both on-site and off-site options for
secondary treatment, according to the CMA spokesman. It sought off-site
treatment at a commercial facility in
2002 when, in the wake of the 2001 terrorist attacks, it adopted an
accelerated disposal plan for its
stockpiles of bulk chemical agent. The Army has claimed that on-site
treatment options for the Newport waste would be
much more expensive than off-site options with costs at least $147
million higher to as much as $347 million higher.
The remaining options are chemical oxidation, wet air oxidation, super
critical water oxidation and incineration, the CMA spokesman says. When
the Army solicited companies for proposals to treat off-site several
years ago, it received responses from just four companies. Two of those
were biodegradation methods, but both of those companies - DuPont in
New Jersey and Perma-Fix in Dayton, OH - are now out of the running,
while the remaining two were proposing to use incineration, a long
controversial method in the chemical demilitarization arena.
Congressional critics, including Rep. Rob Andrews (D-NJ), called for
the GAO investigation. In a statement released after the report came
out, Andrews said he believes the report "played a significant role in
shaping DuPont's decision to cancel" its plans. He promised to work
with the Army to find an alternative waste disposal solution. A staffer
for his office did not have any details on how he planned to work with
the Army.
Activists have long alleged off-site treatment raises chemical
security, environmental and worker safety risks, and continue to
advocate on-site treatment.